Cramer Sees Tech Rebound And Oracle Upside as Data Center Spending Reshapes Market

Oracle shares fell 42.3% over the past month to $142.50, but Cramer framed the rebound as “revenge” trading after Friday’s selloff. Despite massive data center spend (Stargate build cited at $16B plus $30B–$35B largely from Oracle), Oracle reported cloud infrastructure revenue of $5.79B (+93% YoY) and raised its FY2027 non-GAAP EPS target to $8.05 while guiding Q1 FY2027 cloud revenue growth of 58%–64%. The article highlights execution risk—whether Oracle can convert Stargate outfitting spend, supported by $638B RPO (+363% YoY), into durable multi-year cloud margins—amid continued capex scale across the group (e.g., NVIDIA Data Center revenue $75.25B, +92% YoY; Meta capex guidance raised to $125B–$145B).

Analysis

This is less a broad “tech is back” call than a two-tier market: the AI spend complex should keep rewarding the suppliers with pricing power and punishing the balance-sheet owners forced to pre-fund capacity. In the near term, the bounce is technically driven, but the real catalyst path over 1-3 months is whether these capex plans convert into new bookings and whether financing costs stay benign enough to avoid a ROIC reset.

Oracle is the clearest pressure point because the equity has to bridge a wide gap between spending now and monetization later. If customer prepayments and backlog translate into genuine cash conversion by the next print, the stock can squeeze hard; if not, the market will keep underwriting the idea that the buildout is an expensive lease-to-own model with dilution risk. That makes ORCL a better short on rallies than a blind fade, because the stock likely trades on funding headlines and margin cadence before it trades on long-dated revenue promises.

NVDA remains the cleanest beneficiary because it gets paid regardless of whether the end customer’s project economics are elegant. Meta is trickier: the capex step-up is defensible if it protects ad ranking and automation, but the multiple can compress if investors conclude AI spend is outpacing near-term monetization. The contrarian miss is that “AI capex” is not uniformly bullish; it is bullish for toll collectors and potentially value-destructive for the firms that must finance the race.

Key Decisions for Investors

• Long NVDA / short ORCL as a 1-3 month pair trade: own the company selling shovels, short the one most exposed to balance-sheet strain and delayed payback; target 2:1 risk/reward if Oracle financing or FCF headlines deteriorate.
• Sell ORCL rallies or buy a 2-3 month put spread into the next earnings/financing update; thesis breaks if management shows materially improved cash conversion or shifts more capex onto customer-funded structures.
• Keep META on a watchlist rather than chasing the bounce: it is a qualified long only if ad growth stays strong enough to absorb the capex step-up; consider a small hedge via downside put spread if the market starts pricing another guide-up without a revenue re-acceleration.
• Use NVDA strength to add exposure to AI capex beneficiaries rather than chasing broad Nasdaq beta; if the next guidance cycle shows hyperscaler demand still expanding, the follow-through should favor semis over cloud integrators.
• Set an alert for ORCL free cash flow and incremental debt/equity issuance: if financing expands faster than booked revenue, reduce any long exposure immediately; if cash conversion turns positive, cover shorts because the squeeze risk rises quickly.